The pharmaceutical industry imports in France have shown considerable fluctuations over the past decade. Between 2013 and 2019, the industry experienced varying degrees of positive and negative growth, highlighted by a significant downturn in 2015 and 2016 before stabilizing. From 2020 to 2023, imports exhibited a more consistent upward trend, increasing by 14.17% in 2020 and continuing to grow through to 2023. As of 2023, the import value stood at 38.62 Billion USD. Over the last five years, the compound annual growth rate (CAGR) was 5.82%, indicating a robust positive trend.
Looking forward from 2024, forecasts suggest a more moderated growth with a projected 5-year CAGR of 1.93%, expecting a total growth of 10.01% by 2028. This indicates a slightly slower but steady rise in pharmaceutical imports in the near future.
Future trends to watch for include:
•Regulatory Changes: Keep an eye on potential regulatory changes in the pharmaceutical sector which could impact import levels.
•Technological Advancements: Innovations in pharmaceuticals and biotechnology could drive import growth.
•Global Supply Chain Dynamics: Monitor the effects of global supply chain disruptions and geopolitical tensions on import logistics.
•Healthcare Policy Adjustments: Shifts in domestic healthcare policies and investment in local production may alter import volumes.
